Medco profit rises as mail-order generics business grows
The pharmacy benefits manager, which has major operations in Whitestown, said fourth quarter profit rose 24 percent.
Health Care & Life Sciences
Articles
WellPoint to face questioning over rate hike
Executives are scheduled to testify Tuesday before a California legislative committee and on Wednesday before a U.S. House
of Representatives committee about big premium increases.
Lilly, Merck, Pfizer starting research center
Three major U.S. drugmakers said they have formed a not-for-profit company in Asia to focus on cancer research and treatments.
California regulator finds Anthem Blue Cross violations
California’s insurance regulator said Monday his office has found more than 700 violations by the state’s largest for-profit
health insurer, a subsidiary of Indianapolis-based WellPoint.
WellPoint gets tax delay in Obama health plan
Insurers WellPoint Inc. and others would get a delay in taxes on premiums and high-cost medical benefits, along with additional
funding for expanding Medicaid, under a White House proposal
Obama endorses new taxes, more drugmaker fees
Obama, seeking to break an impasse over health-care legislation, proposes a plan that includes the first Medicare tax on unearned
income such as capital gains and higher fees on drugmakers.
Insurers warn of problems with federal regulator
President Obama’s latest push for a health care overhaul could drive health plans around the country into insolvency, according
to an insurance trade group.
New Obama health proposal would limit rate hikes
President Barack Obama is making a fresh attempt to rescue his health care overhaul by proposing a measure that would allow
the government to deny or roll back egregious insurance premium increases that infuriate consumers.
A closer look at WellPoint’s health insurance profits
At the heart of the debate is the question of what should be a fair profit for health insurers. WellPoint CEO Angela Braly
will likely be grilled on the issue when she appears at a Congressional hearing Wednesday.
White House plans new rules for health insurers
President Obama will release a proposal to restart the health-care debate before a bipartisan White House meeting on Feb.
25, one day after WellPoint officials testify before Congress about steep rate increases.
Teva gets European OK to sell generic of Lilly’s Evista
Evista generated $1.03 billion in sales last year, of which $348.1 million came outside the United States.
Lilly asks shareholders to lower takeover barrier
Eli Lilly and Co. directors have recommended that shareholders toss out the
drugmaker's most potent protection against unwanted takeovers: an 80-percent supermajority vote threshold for any shareholder
mutiny to succeed.
WellPoint’s health insurance rate hike spurs legislative inquiry
The furor over WellPoint Inc.’s premium hikes have migrated from California to Indiana, where state lawmakers held a
high-profile hearing.
Indiana companies that serve pharmaceutical industry grew in 2009
The firms continued to grow over the last year but face increasing challenges, according to a new report by Indianapolis-based
life sciences trade group BioCrossroads.
Vortek Surgical moving HQ to Brownsburg, adding 60 jobs
Indianapolis-based Vortek Surgical LLC will relocate to Brownsburg, expanding its headquarters, manufacturing and distribution
operations and creating more than 60 jobs in the next three years.
Hamilton County ranked Indiana’s healthiest county
Nationwide report ranks Marion County 87th out of 92 Indiana counties in health factors and 80th in health outcomes.
WellPoint rate hikes spark protest in Indianapolis
Congressman Andre Carson will make remarks Thursday during a public chastising of Indianapolis-based health insurer for 21-percent rate
hike on individuals.
WellPoint, insurance commissioner get earful from lawmakers
State House insurance committee chair grills executives about WellPoint’s 21-percent premium increase for individual policyholders
in Indiana.
Lilly settles Arkansas Zyprexa suit for $18.5M
Arkansas Attorney General Dustin McDaniel on Tuesday announced an $18.5 million settlement of a lawsuit with Eli Lilly &
Co. over off-label marketing of the anti-psychotic drug Zyprexa.
State lawmakers to probe WellPoint premium hikes
Three WellPoint executives will be on hand Wednesday morning to answer questions about premium increases on its individual
policies, which have risen as high as 39 percent this year.